Beijing Beilu Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Beijing Beilu Pharmaceutical has a total shareholder equity of CN¥1.8B and total debt of CN¥861.4M, which brings its debt-to-equity ratio to 46.6%. Its total assets and total liabilities are CN¥3.0B and CN¥1.2B respectively.
Key information
46.6%
Debt to equity ratio
CN¥861.37m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥698.58m |
| Equity | CN¥1.85b |
| Total liabilities | CN¥1.16b |
| Total assets | CN¥3.01b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300016's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥447.3M).
Long Term Liabilities: 300016's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥715.4M).
Debt to Equity History and Analysis
Debt Level: 300016's net debt to equity ratio (8.8%) is considered satisfactory.
Reducing Debt: 300016's debt to equity ratio has increased from 0% to 46.6% over the past 5 years.
Debt Coverage: 300016's debt is not well covered by operating cash flow (15.6%).
Interest Coverage: Insufficient data to determine if 300016's interest payments on its debt are well covered by EBIT.